The challenge of regulating anticoagulant drugs: focus on warfarin.
Mann
Kenneth G
KG
Vermont College of Medicine, Department of Biochemistry, University of Vermont, Burlington, Vt 05405, USA. Kenneth.Mann@uvm.edu
D000925:Anticoagulants / Q000378:metabolism / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000502:physiology*; D001779:Blood Coagulation Factors / Q000502:physiology; D001798:Blood Proteins / Q000502:physiology*; D006470:Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D019934:International Normalized Ratio; D011517:Prothrombin Time; D013917:Thrombin / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology*; D013925:Thromboplastin; D014812:Vitamin K / Q000037:antagonists & inhibitors*; D014859:Warfarin / Q000378:metabolism / Q000627:therapeutic use*
D000925:Anticoagulants; D001779:Blood Coagulation Factors; D001798:Blood Proteins; D014812:Vitamin K; D014859:Warfarin; D013925:Thromboplastin; D013917:Thrombin